---
title: "Neurogene says cash runway extends into Q1 2029 after USD 134.8 million stock offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291529352.md"
description: "Neurogene extended its cash runway into Q1 2029 following a public equity offering that generated approximately $134.8 million in net proceeds. The financing involved the sale of 3,500,000 common shares at $30 each and pre-funded warrants for up to 666,666 shares. Underwriters fully exercised their option for an additional 624,999 shares. The transaction is scheduled to close on July 2."
datetime: "2026-07-02T10:04:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291529352.md)
  - [en](https://longbridge.com/en/news/291529352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291529352.md)
---

# Neurogene says cash runway extends into Q1 2029 after USD 134.8 million stock offering

-   Neurogene mapped out a longer operating runway into the first quarter of 2029 following a public equity offering expected to generate about $134.8 million in net proceeds. \* The financing centers on 3,500,000 common shares priced at USD 30 per share. \* It also includes pre-funded warrants covering up to 666,666 shares priced at USD 30 per share, net of a USD 0.000001 exercise price. \* Underwriters exercised in full a 30-day option for an additional 624,999 shares, with the deal set to close July 2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001404644-26-000050), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)

## Related News & Research

- [Neurogene President, CFO Christine Mikail Cvijic sells 4,800 shares for $173,468.40](https://longbridge.com/en/news/291993400.md)
- [Neurogene President, CFO Christine Mikail Cvijic sells 4,800 common shares for $166,407.28](https://longbridge.com/en/news/291596148.md)
- [Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22](https://longbridge.com/en/news/294696340.md)
- [CDT Equity issues pre-funded warrants for up to 12,131,770 shares to lift Sarborg stake to 22.7%](https://longbridge.com/en/news/294693882.md)
- [QT Imaging stockholders elect Zeev Weiner, Bryan Timm as Class II directors](https://longbridge.com/en/news/294109281.md)